Inhibition of morphological transition and hyphae extension in Candida spp. by occidiofungin

Aims To assess the efficacy of the antifungal, occidiofungin, against Candida albicans and Candida tropicalis morphological transformation. Methods and Results Susceptibility assays and morphological data were used to demonstrate that occidiofungin effectively targets C. albicans and C. tropicalis undergoing morphological transformation. Susceptibility assays found that cell sensitivity to occidiofungin varied with the media conditions used for morphological switching. Microscopy data showed that occidiofungin inhibited hyphae formation when added at the time of morphological induction and hyphal extension when added within the first hour following hyphae induction. Immunoblot analysis demonstrated that occidiofungin addition prevented activation of Cek1p MAPK signalling. Conclusions The data indicated that the antimicrobial compound, occidiofungin, effectively targets hyphae elongation in Candida spp. and suggests the biological target of occidiofungin is necessary for the morphological changes associated with yeast-to-hyphae switching. Significance and Impact of the Study Findings from this study demonstrated that occidiofungin effectively targets the invasive growth of dimorphic Candida which suggests this compound may also inhibit the heterogenous population of cells present in a clinical setting. This presents occidiofungin as a promising candidate for the treatment of Candida associated infections.

Automated summary

The study demonstrates that occidiofungin effectively targets hyphae elongation in Candida species by inhibiting the morphological changes associated with yeast-to-hyphae switching. This suggests that occidiofungin could be a promising candidate for the treatment of Candida associated infections, as it may also inhibit the heterogeneous population of cells present in a clinical setting.